Proteus Digital Health
2600 Bridge Parkway
Suite 101
Redwood City
California
94065
United States
Tel: 1-650-632-4031
Fax: 1-650-632-4071
Website: http://www.proteusdigitalhealth.com/
22 articles about Proteus Digital Health
-
Proteus Digital Health® Announces First State Medicaid Outcomes-Based Initiative with Digital Medicines
5/5/2020
Tennessee’s Medicaid program, TennCare, will cover Proteus Discover® to aid patients and physicians in the treatment of Hepatitis C.
-
Proteus Digital Health® DigiMeds Data Demonstrates 99% of Hepatitis C Patients at High Risk for Nonadherence Achieved a Cure
11/12/2019
Patients at high risk for nonadherence and commonly denied access to direct-acting antivirals achieved sustained virologic response with DigiMeds treatment
-
Proteus Digital Health’s Olivia Ware Named in Savoy Magazine’s 2019 Most Influential Women in Corporate America
7/31/2019
With expertise in a range of industries, the selected women embody talent, leadership and grace while executing critical roles for some of the largest corporations in the world.
-
Guiding Principles on Ethics in Digital Health Produced During a Seminar at Stanford Libraries
2/21/2019
Proteus Digital Health and more than 30 representatives from technology, pharmaceutical, healthcare, public policy, law and bioethics convene at Stanford to address the responsibility around management of personal data.
-
Proteus Digital Health® Launches Digital Oncology Medicines to Improve Patient Outcomes
1/17/2019
Proteus, Fairview Health Services, and University of Minnesota Health are First to Provide Digital Medicines to Cancer Patients
-
Otsuka and Proteus Digital Health Announce Expanded Collaboration Agreement to Advance Digital Medicines for Mental Health
10/11/2018
Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Proteus Digital Health (Proteus) today announce the signing of an expanded global collaboration agreement that will strengthen the relationship between the two companies for the further development and commercialization of a portfolio of medicines including the ABILIFY MYCITE® (aripiprazole tablets with sensor) offering, which received NDA approval from the U.S. Food and Drug Administration in November 2017.
-
Getting patients to adhere to long-term treatments can be difficult. There are a number of new therapies that will monitor whether or not patients are sticking to their regimen.
-
Executive Chairman of Anthem Inc., Joseph Swedish, Joins the Board of Proteus Digital Health
2/13/2018
Proteus Digital Health announced today that Joseph Swedish, the Executive Chairman of Anthem Inc., has joined its Board of Directors.
-
The embedded sensor will help keep track of whether patients are adhering to their prescriptions.
-
Former U. S. Surgeon General Dr. Regina Benjamin Joins The Board Of Proteus Digital Health
9/5/2017
-
Bay Area's Proteus Digital Health Taps Novartis AG Exec as New CFO
8/24/2017
-
Otsuka Pharma And Proteus Digital Health Resubmit Application To FDA For First Digital Medicine
5/23/2017
-
FDA Spurns Otsuka Pharma, Proteus Digital Health's Drug/Device Combo
4/27/2016
-
Proteus Digital Health Nabs $50 Million Equity Financing
4/15/2016
-
Proteus Digital Health, Inc. Presents Interim Results At American College of Cardiology From A Randomized Controlled Clinical Study Of Proteus Discover
4/4/2016
-
Gloria Pharma Invests $40 Million In Proteus Digital Health, Inc.; Gains Option For China JV
3/1/2016
-
U.S. FDA Accepts First Digital Medicine New Drug Application For Otsuka Pharma And Proteus Digital Health, Inc.
9/11/2015
-
4 Ways Proteus Digital Health, Inc. Is Using Smart Pill To Help Doctors Personalize Patient Care
8/4/2014
-
Proteus Digital Health, Inc. Snags $172 Million+ Series G
7/30/2014
-
Proteus Digital Health, Inc. Nabs $120 Million, Brings In Hewlett-Packard Veteran As CFO
6/4/2014